Other languages Bausch Health Companies Inc. Toronto S.E.

Equities

BHC

CA0717341071

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
8.95 ^CAD	+4.19%		+2.87%	-15.71%

May. 28	Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens	MT
May. 23	Bausch Health Announces Wider Public Drug Plan Coverage for Uceris in Canada	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens	May. 28
Bausch Health Announces Wider Public Drug Plan Coverage for Uceris in Canada	May. 23
Bausch Health Companies - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	May. 20
Bausch Health Companies Inc. and Salix Pharmaceuticals to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	May. 17
Bausch Health Announces 2024 Annual Meeting of Shareholder Results	May. 16
RBC Notes Updates on Bausch Xifaxan Patent Litigation with Norwich	May. 15
Bausch Health Companies Inc. Approves Directorate Appointments	May. 15
Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters	May. 14
Bausch Health Brief: Announcing Updates Related to Norwich XIFAXAN Matters	May. 14
RBC Noes Bausch Health Filing For Rehearing in Appellate Court	May. 13
RBC Lowers Bausch Health Target to US$10, Maintains Sector Perform	May. 03
Bausch Health Announces First Quarter 2024 Results	May. 03
Bausch Health Shares Fall Following Q1 Results	May. 02
Bausch Health Q1 Net Loss Narrows on Higher Revenue, Confirms 2024 Revenue Guidance	May. 02
Transcript : Bausch Health Companies Inc., Q1 2024 Earnings Call, May 02, 2024	May. 02
Bausch: Q1 Earnings Snapshot	May. 02
Bausch Health Brief: Reaffirmed full-year Revenue and Adjusted EBITDA (non-GAAP) guidance	May. 02
Bausch Health Brief: Q1 revenues of US$2.15 billion, up 11% on a Reported and 8% on an Organic basis	May. 02
Bausch Health Companies Inc. Reaffirms Earnings Guidance for the Full Year 2024	May. 02
Bausch Health Companies Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bausch Health Companies Inc. Toronto S.E.

Equities

BHC

CA0717341071

Other languages

Filters